Top Buy
| Wertpapier | Buy | Sell | Buy (1W) | Sell (1W) ▼ | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Adverum Biotechnologies Inc. | 8 | 0 | 0 | 0 | 1,38 € | 13,07 € | 847,45 % |
| ProQR Therapeutics N.V. | 8 | 2 | 0 | 0 | 1,50 € | 3,03 € | 102,29 % |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | 75,16 € | 100,00 € | 33,05 % |
| Rhythm Pharmaceuticals | 15 | 0 | 0 | 0 | 40,40 € | 46,08 € | 14,07 % |
| Nektar Therapeutics | 4 | 1 | 0 | 0 | 1,12 € | 2,40 € | 114,67 % |
| Merck & Co. Inc. | 35 | 1 | 3 | 0 | 116,20 € | 125,02 € | 7,59 % |
| Catalyst Pharmaceutical Partners Inc | 14 | 0 | 0 | 0 | 14,00 € | 24,13 € | 72,38 % |
| Novo Nordisk A/S | 5 | 0 | 1 | 0 | 185,00 € | 195,00 € | 5,41 % |
| Trinity Biotech ADR | 25 | 0 | 1 | 0 | 0,41 € | - | - |
| Verastem Inc. | 12 | 0 | 2 | 0 | 2,62 € | 18,50 € | 606,03 % |
| Xeris Biopharma Holdings Inc. | 6 | 0 | 0 | 0 | 1,92 € | 4,39 € | 128,83 % |
| Abbott Laboratories | 21 | 0 | 2 | 0 | 93,74 € | 115,05 € | 22,73 % |
| UCB S.A. | 1 | 0 | 0 | 0 | 144,00 € | - | - |
| Perrigo Co. plc | 4 | 0 | 0 | 0 | 24,50 € | 35,01 € | 42,88 % |
| Vertex Pharmaceuticals Inc. | 58 | 2 | 4 | 0 | 450,95 € | 470,15 € | 4,26 % |
| Novavax Inc. | 4 | 1 | 0 | 0 | 11,01 € | 17,59 € | 59,84 % |
| Dynavax Technologies Corp | 3 | 0 | 0 | 0 | 10,15 € | 27,02 € | 166,17 % |
| Grifols S.A. | 1 | 0 | 0 | 0 | 10,04 € | - | - |
| Cytokinetics Inc. | 34 | 1 | 0 | 0 | 51,00 € | 83,56 € | 63,84 % |
| Halozyme Therapeutics Inc. | 20 | 0 | 0 | 0 | 49,00 € | 52,75 € | 7,65 % |
| Ipsen S.A. | 1 | 0 | 0 | 0 | 108,60 € | 109,00 € | 0,37 % |
| Clinuvel Pharmaceuticals | 1 | 0 | 0 | 0 | 9,26 € | - | - |
| Cellectis Nom. | 5 | 0 | 3 | 0 | 1,70 € | 2,50 € | 47,23 % |
| Actinogen Ltd | 1 | 0 | 0 | 0 | 0,044 € | - | - |
| EyePoint Pharmaceuticals Inc. | 22 | 1 | 0 | 0 | 7,84 € | 27,83 € | 255,17 % |